Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Managing Osteoporosis: A Survey of Knowledge, Attitudes and Practices among Primary Care Physicians in Israel.

Fogelman Y, Goldshtein I, Segal E, Ish-Shalom S.

PLoS One. 2016 Aug 5;11(8):e0160661. doi: 10.1371/journal.pone.0160661.

2.

Vitamin D Status and Quality of Life in Healthy Male High-Tech Employees.

Tepper S, Dabush Y, Shahar DR, Endevelt R, Geva D, Ish-Shalom S.

Nutrients. 2016 Jun 15;8(6). pii: E366. doi: 10.3390/nu8060366.

3.

Differences in homeostatic model assessment (HOMA) values and insulin levels after vitamin D supplementation in healthy men: a double-blind randomized controlled trial.

Tepper S, Shahar DR, Geva D, Ish-Shalom S.

Diabetes Obes Metab. 2016 Jun;18(6):633-7. doi: 10.1111/dom.12650.

PMID:
26890031
4.

Bioavailability, rheology and sensory evaluation of fat-free yogurt enriched with VD3 encapsulated in re-assembled casein micelles.

Levinson Y, Ish-Shalom S, Segal E, Livney YD.

Food Funct. 2016 Mar;7(3):1477-82. doi: 10.1039/c5fo01111f.

PMID:
26878710
5.

Cost and Consequences of Nonadherence With Oral Bisphosphonate Therapy: Findings From a Real-World Data Analysis.

Sharman Moser S, Yu J, Goldshtein I, Ish-Shalom S, Rouach V, Shalev V, Modi A, Chodick G.

Ann Pharmacother. 2016 Apr;50(4):262-9. doi: 10.1177/1060028015626935.

PMID:
26783359
6.

Atypical Femoral Fractures: Radiological Evaluation and Bisphosphonate Exposure.

Tripto-Shkolnik L, Segal E, Jaffe A, Ish-Shalom S, Bachrach R, Nachtigal A, Militianu D.

Isr Med Assoc J. 2015 Sep;17(9):554-8.

7.

Association of gastrointestinal events and osteoporosis treatment initiation in newly diagnosed osteoporotic Israeli women.

Yu J, Goldshtein I, Shalev V, Chodick G, Ish-Shalom S, Sharon O, Modi A.

Int J Clin Pract. 2015 Sep;69(9):1007-14. doi: 10.1111/ijcp.12676.

8.

Renal impairment among postmenopausal women with osteoporosis from a large health plan in Israel.

Yu J, Goldshtein I, Shalev V, Chodick G, Ish-Shalom S, Sharon O, Modi A.

Arch Osteoporos. 2015;10:210. doi: 10.1007/s11657-015-0210-y.

PMID:
25753617
9.

Systemic glucocorticoids: important issues and practical guidelines for the dermatologist.

Dodiuk-Gad RP, Ish-Shalom S, Shear NH.

Int J Dermatol. 2015 Jun;54(6):723-9. doi: 10.1111/ijd.12642. Review.

PMID:
25683616
10.

Atypical osteoporotic fractures: impact on therapeutic decision making in osteoporosis.

Ish-Shalom S.

Isr Med Assoc J. 2014 Feb;16(2):110-2. No abstract available.

11.

Identifying the threshold for vitamin D insufficiency in relation to cardiometabolic markers.

Tepper S, Shahar DR, Geva D, Avizohar O, Nodelman M, Segal E, Ish-Shalom S.

Nutr Metab Cardiovasc Dis. 2014 May;24(5):489-94. doi: 10.1016/j.numecd.2013.10.025.

PMID:
24418378
12.

Predictors of serum 25(Oh)D increase following bimonthly supplementation with 100,000IU vitamin D in healthy, men aged 25-65 years.

Tepper S, Shahar DR, Geva D, Ish-Shalom S.

J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:163-6. doi: 10.1016/j.jsbmb.2013.12.005. Review.

PMID:
24333798
13.

Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties.

Golan D, Halhal B, Glass-Marmor L, Staun-Ram E, Rozenberg O, Lavi I, Dishon S, Barak M, Ish-Shalom S, Miller A.

BMC Neurol. 2013 Jun 14;13:60. doi: 10.1186/1471-2377-13-60.

14.

The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis.

Golan D, Staun-Ram E, Glass-Marmor L, Lavi I, Rozenberg O, Dishon S, Barak M, Ish-Shalom S, Miller A.

Brain Behav Immun. 2013 Aug;32:180-5. doi: 10.1016/j.bbi.2013.04.010.

PMID:
23665342
15.

Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.

Devogelaer JP, Sambrook P, Reid DM, Goemaere S, Ish-Shalom S, Collette J, Su G, Bucci-Rechtweg C, Papanastasiou P, Reginster JY.

Rheumatology (Oxford). 2013 Jun;52(6):1058-69. doi: 10.1093/rheumatology/kes410.

16.

Vitamin D deficiency in oncology patients--an ignored condition: impact on hypocalcemia and quality of life.

Segal E, Felder S, Haim N, Yoffe-Sheinman H, Peer A, Wollner M, Shen-Or Z, Ish-Shalom S.

Isr Med Assoc J. 2012 Oct;14(10):607-12.

17.

Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study.

Bloch M, Ish-Shalom S, Greenman Y, Klein E, Latzer Y.

Psychiatry Res. 2012 Dec 30;200(2-3):544-9. doi: 10.1016/j.psychres.2012.07.012.

PMID:
22858403
18.

Vitamin D status in young HIV infected women of various ethnic origins: incidence of vitamin D deficiency and possible impact on bone density.

Shahar E, Segal E, Rozen GS, Shen-Orr Z, Hassoun G, Kedem E, Pollack S, Ish-Shalom S.

Clin Nutr. 2013 Feb;32(1):83-7. doi: 10.1016/j.clnu.2012.05.022.

PMID:
22732141
19.

Osteocalcin is independently associated with body mass index in adolescent girls.

Dubnov-Raz G, Ish-Shalom S, Chodick G, Rozen GS, Giladi A, Constantini NW.

Pediatr Obes. 2012 Aug;7(4):313-8. doi: 10.1111/j.2047-6310.2012.00058.x.

PMID:
22577088
20.

Stability and bioavailability of vitamin D nanoencapsulated in casein micelles.

Haham M, Ish-Shalom S, Nodelman M, Duek I, Segal E, Kustanovich M, Livney YD.

Food Funct. 2012 Jul;3(7):737-44. doi: 10.1039/c2fo10249h.

PMID:
22569895
Items per page

Supplemental Content

Loading ...
Support Center